Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Bayer describes novel radioimmunoconjugate BAY-1862864 entering phase I development

May 4, 2016

GlaxoSmithKline quadrivalent influenza vaccine safe, immunogenic in children under 3 years old

May 4, 2016

Phase II dose of bispecific antibody MCLA-128 defined in first-in-human solid tumor study

May 4, 2016

INCB-059872 demonstrates promising in vitro and in vivo activity in models of AML

May 4, 2016

Novel benzylpyrazole-based BUB1 kinase inhibitors with antitumor activity

May 4, 2016

Rigel identifies MerTK inhibitors for treating cancer

May 3, 2016

Novel anti-CD352 ADC SGN-CD352A

May 3, 2016

Arenavirus entry inhibitor from Kineta shows preclinical efficacy

May 3, 2016

Further trials planned after phase Ia study of cyclopropavir in healthy subjects

May 3, 2016

Novel gemcitabine prodrug shows improved antitumor efficacy

May 3, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...